Last updated on April 2019

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis


Brief description of study

The primary objectives of this study are to evaluate the safety and efficacy of filgotinib in the induction and maintenance treatment of moderately to severely active ulcerative colitis (UC) in participants who are biologic-naive and biologic-experienced.

Participants who complete the study, or do not meet protocol response or remission criteria at Week 10 will have the option to enter a separate, long-term extension (LTE) study (Gilead Study GS-US-418-3899).

Clinical Study Identifier: NCT02914522

Find a site near you

Start Over

The Alfred Hospital

Melbourne, Australia
6.21miles
  Connect »

Footscray Hospital

Footscray, Australia
7.06miles
  Connect »